SRRA NASDAQ
Sierra Oncology, Inc.
1W: +0.1%
1M: +0.4%
3M: +69.8%
1Y: +182.4%
3Y: +149.9%
5Y: +12.7%
$54.99
Last traded 2022-06-30 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
-100.0% ▼
Gross Profit
$0
-100.0% ▼
Operating Income
-$95M
-45.8% ▼
Net Income
-$95M
-17.0% ▼
EPS (Diluted)
$-7.14
+7.3% ▲
EBITDA
-$94M
-17.2% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $300K | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | -100.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $300K | $0 |
| Gross Margin | — | — | — | 100.0% | — |
| R&D Expenses | $30M | $41M | $53M | $45M | $67M |
| SG&A Expenses | $12M | $14M | $14M | $20M | $27M |
| Operating Expenses | $43M | $55M | $67M | $65M | $95M |
| Operating Income | -$43M | -$55M | -$67M | -$65M | -$95M |
| Operating Margin | — | — | — | -21647.0% | — |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$42M | -$54M | -$88M | -$81M | -$95M |
| Tax Expense | $156K | -$302K | -$160K | $142K | -$3K |
| Net Income | -$42M | -$53M | -$88M | -$81M | -$95M |
| Net Margin | — | — | — | -26967.3% | — |
| EPS (Diluted) | $-33.68 | $-30.16 | $-30.30 | $-7.70 | $-7.14 |
| EBITDA | -$42M | -$54M | -$88M | -$81M | -$94M |
| Shares Outstanding | 1M | 2M | 3M | 11M | 13M |